Takeda is looking to offload its cell therapy platform and preclinical assets to a yet-unidentified external partner. 137 employees will be let go as part of the move.
With layoffs happening at biopharma companies of all sizes, some may wonder which jobs are safest. Talent acquisition experts spoke to BioSpace about the areas and roles they recommend to biotech and pharma professionals hoping to avoid staff cuts.
Under interim IRS guidance issued Tuesday, corporations can disregard unrealized gains and losses on their digital assets when determining whether they are subject to the AMT.
The Internal Revenue Service’s Independent Office of Appeals launched a two-year pilot program designed to increase taxpayers’ awareness and use of PAM.